Since 2008, downstream purification issues have become progressively more acute problems for biomanufacturers. But that’s begun to change this year, according to results from BioPlan Associates’ 9th ...
Enveloped viruses have tremendous potential in a number of areas of great interest to biotech and pharma firms including gene therapy and vaccination. These viruses, which are typically produced in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback